Cronos Group Inc. (CRON.TO)
CAD 2.72
(-2.51%)
CAD 2.72
(-2.51%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 1.14 Billion USD | -6.01% |
| 2022 | 1.21 Billion USD | -13.22% |
| 2021 | 1.39 Billion USD | -27.42% |
| 2020 | 1.92 Billion USD | -7.88% |
| 2019 | 2.09 Billion CAD | 990.4% |
| 2018 | 191.71 Million CAD | 138.62% |
| 2017 | 80.34 Million CAD | 151.71% |
| 2016 | 31.91 Million CAD | 200.82% |
| 2015 | 10.61 Million CAD | 23.78% |
| 2014 | 8.57 Million CAD | 565.74% |
| 2013 | 1.28 Million CAD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 1.1 Billion USD | -2.77% |
| 2024 Q2 | 1.09 Billion USD | -1.58% |
| 2023 Q3 | 1.15 Billion USD | -1.56% |
| 2023 FY | 1.14 Billion USD | -6.01% |
| 2023 Q1 | 1.15 Billion USD | -4.41% |
| 2023 Q2 | 1.16 Billion USD | 0.76% |
| 2023 Q4 | 1.14 Billion USD | -0.87% |
| 2022 Q3 | 1.23 Billion USD | -7.11% |
| 2022 FY | 1.21 Billion USD | -13.22% |
| 2022 Q1 | 1.37 Billion USD | -1.91% |
| 2022 Q4 | 1.21 Billion USD | -1.98% |
| 2022 Q2 | 1.33 Billion USD | -2.83% |
| 2021 Q2 | 1.83 Billion USD | -2.27% |
| 2021 FY | 1.39 Billion USD | -27.42% |
| 2021 Q1 | 1.88 Billion USD | -2.31% |
| 2021 Q4 | 1.39 Billion USD | -8.95% |
| 2021 Q3 | 1.53 Billion USD | -16.5% |
| 2020 Q2 | 1.91 Billion USD | -0.91% |
| 2020 Q3 | 1.91 Billion USD | 0.45% |
| 2020 Q4 | 1.92 Billion USD | 0.35% |
| 2020 FY | 1.92 Billion USD | -7.88% |
| 2020 Q1 | 1.92 Billion USD | -7.77% |
| 2019 FY | 2.09 Billion CAD | 990.4% |
| 2019 Q4 | 2.09 Billion CAD | 0.17% |
| 2019 Q3 | 2.08 Billion CAD | 2.71% |
| 2019 Q2 | 2.03 Billion CAD | 0.56% |
| 2019 Q1 | 2.02 Billion CAD | 954.02% |
| 2018 Q4 | 191.71 Million CAD | 5.65% |
| 2018 Q1 | 108.59 Million CAD | 35.17% |
| 2018 FY | 191.71 Million CAD | 138.62% |
| 2018 Q3 | 181.46 Million CAD | 1.37% |
| 2018 Q2 | 179.01 Million CAD | 64.85% |
| 2017 Q3 | 64.01 Million CAD | 51.11% |
| 2017 Q2 | 42.36 Million CAD | -3.6% |
| 2017 FY | 80.34 Million CAD | 151.71% |
| 2017 Q1 | 43.94 Million CAD | 37.69% |
| 2017 Q4 | 80.34 Million CAD | 25.5% |
| 2016 Q2 | 12.13 Million CAD | 13.54% |
| 2016 Q4 | 31.91 Million CAD | 5.94% |
| 2016 Q3 | 30.12 Million CAD | 148.26% |
| 2016 FY | 31.91 Million CAD | 200.82% |
| 2016 Q1 | 10.68 Million CAD | 0.73% |
| 2015 Q3 | 7.09 Million CAD | -12.21% |
| 2015 Q1 | 7.41 Million CAD | 0.0% |
| 2015 FY | 10.61 Million CAD | 23.78% |
| 2015 Q4 | 10.61 Million CAD | 49.63% |
| 2015 Q2 | 8.07 Million CAD | 8.85% |
| 2014 Q3 | 661.26 Thousand CAD | 181.68% |
| 2014 FY | 8.57 Million CAD | 565.74% |
| 2014 Q2 | 234.76 Thousand CAD | 0.0% |
| 2013 FY | 1.28 Million CAD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Aurora Cannabis Inc. | 838.67 Million CAD | -35.939% |
| Avicanna Inc. | 21.97 Million CAD | -5089.019% |
| Avant Brands Inc. | 82.55 Million CAD | -1281.051% |
| Cardiol Therapeutics Inc. | 36.7 Million CAD | -3006.456% |
| Crescita Therapeutics Inc. | 24.59 Million CAD | -4534.869% |
| Knight Therapeutics Inc. | 945.49 Million CAD | -20.581% |
| MediPharm Labs Corp. | 63.93 Million CAD | -1683.138% |
| OrganiGram Holdings Inc. | 298.45 Million CAD | -281.996% |
| Canopy Growth Corporation | 1.3 Billion CAD | 12.323% |
| Willow Biosciences Inc. | 6.67 Million CAD | -16985.044% |
| Auxly Cannabis Group Inc. | 261.9 Million CAD | -335.306% |